Coronaviruses are a collective name for a group of viruses that refer to viruses that can infect both humans and animals. They can cause respiratory diseases. Minor illnesses are like the common cold, and severe illnesses can develop into pneumonia. Animal coronaviruses infect humans and spread among humans is extremely rare. There is no vaccine and antibiotics which are effective against the virus. Without any specific treatment plan, the medical staff usually treat the patient’s existing symptoms to make the patient feel comfortable.
The most common tests for COVID-19 includes taking a swab from a patient’s throat and nose and checking them for the genetic footprint of the virus. They are called PCR tests. The first PCR tests for COVID-19 were developed very rapidly – within two weeks of the disease being identified – and they are now part of the World Health Organization (WHO) recommended protocol for dealing with the disease.
Global COVID-19 Testing Kit Market estimated to grow with a noteworthy rate during the forecast period, 2020-2027. The rapid surge in the coronaviruses affected patients across the world will fuel the global COVID-19 testing kit market in the upcoming periods. Additionally, shortages in test-related supplies like swabs, virus control samples, and RT-PCR instruments for controlling the COVID-19 virus estimated to influence the global COVID-19 testing kit industry. According to WHO, The coronavirus COVID-19 is affecting 192 countries and territories around the world and international conveyance. According to WHO, the latest coronavirus cases worldwide are 339,182.
Moreover, the application of the COVID-19 test kit is detecting virus, monitoring, and intended to track the spread of diseases like influenza, which will lead the trigger the growth of the COVID-19 testing kit market size. Additionally, many foundations have invested in curing diseases such as Gates Foundation has poured about $20 million into the effort. The foundation has also committed $5 million to the local response efforts to combat the disease in including the expansion of testing and analysis. WHO Operations Supply and Logistics (OSL) continues to support COVID-19 emergency operations where global demand for critical items continues to outpace global supply. The COVID-19 testing Kit has many advantages like it does not require a laboratory, which could help alleviate pressure on the government’s health agency, and people at home can use it, which would help take the burden off an already strained health system.
According to WHO, there are currently 339,182 confirmed cases and 14,703 deaths from the coronavirus COVID-19 outbreak as of March 23, 2020. Rapid collection and testing of appropriate specimens from patients meeting the suspect case definition for COVID-19 is a priority for clinical management and outbreak control.
Testing helps infected people to know that they are infected, which is helping them receive the required care, and it can help them take measures to reduce the probability of spreading the infection to others. Testing is also crucial for knowing the appropriate response to the pandemic. It allows for understanding the spread of the disease and taking evidence-based measures to slow down the spread of the disease.
Based on type, the global COVID-19 Testing Kit market classified into Equipment and Extraction Kits, rRT-PCR Test Kits, and Reagents9 (rRT-PCR Enzyme Mastermix, Human Specimen Control, and EUA Positive Control. The rRT-PCR Test Kits segment accounted for gaining a major share in the market in 2019, owing to the growing demand for a test kit that detects the virus that causes COVID-19 in respiratory specimens.
Based on the application, the global COVID-19 Testing Kit market classified into Detecting Virus, Monitoring, and Others. The Detection segment estimated to dominate due to benefits such as it detects the early stage of the disease with a viral load. It recognizes major respiratory symptoms, including the patient’s throat and nose.
Based on end-user, the global COVID-19 Testing Kit market categorized into Hospitals, Clinics, Pharmacy stores, Pathology centers, and Others. Hospitals segment expected to gain maximum revenue owing to the massive demand for COVID-19 Testing Kit in hospitals for early detected patients and requirements for daily basis monitoring for quarantine patients.
The pharmacy store will drive by the rise in demand for the COVID-19 testing kit by people for testing daily.
Based on geography, the global COVID-19 Testing Kit market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2027, owing to growth in number patients affected from COVID-19 along with the validation of testing and equipment manufacturing companies by USA governments.
The Asia Pacific and Europe will drive by the surge in the number of patients affected by the novel COVID-19, especially in Europe.
Companies such as Cepheid Inc., AlphaBiolabs Ltd, Thermo Fisher Scientific, Primerdesign Ltd, Hologic, Inc., Roche Holding AG, Cosara Diagnostics Pvt Ltd, Abbott Laboratories, Quidel Corporation, and QIAGEN are the key players in the Global COVID-19 Testing Kit Market.